Home > Insider Trading > Filing (0001104659-24-082328)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1137883	Brainstorm Cell Therapeutics Inc.	BCLI	Biological Products, (No Disgnostic Substances) (2836)	207273918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2019599	B. Ibrahim Dagher	C/O Brainstorm Cell Therapeutics Inc. 1325 Avenue Of The Americas 28Th Floor New York NY 10019	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-07-19	63,000	$0.35	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	160,000	Indirect	By the Reporting Person's Roth IRA
Common Stock	30,000	Indirect	See Note

Footnotes

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.3455 to $0.366, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Represents shares held in a custodial account under the Uniform Transfers to Minors Act for the benefit of the Reporting Person's child. The Reporting Person is the custodian of such account. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.